These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 14223542)

  • 21. FIBRINOLYTIC THERAPY OF THROMBOPHLEBITIS. TWENTY-FIVE CASES STUDIED WITH SERIAL VENOGRAMS.
    HECKER SP
    Calif Med; 1964 Jul; 101(1):23-9. PubMed ID: 14179527
    [TBL] [Abstract][Full Text] [Related]  

  • 22. THE FIBRINOLYTIC SYSTEM IN HEALTH AND DISEASE.
    JOHNSON AJ; NEWMAN J
    Semin Hematol; 1964 Oct; 1():401-31. PubMed ID: 14225683
    [No Abstract]   [Full Text] [Related]  

  • 23. THE LABORATORY CONTROL OF THROMBOLYTIC THERAPY.
    HAWKEY C; HOWELL M
    J Clin Pathol; 1964 May; 17(3):287-91. PubMed ID: 14159462
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PRACTICAL METHOD FOR THROMBOLYTIC THERAPY WITH STREPTOKINASE. MAINTENANCE OF NEARLY COMPLETE PLASMINOGEN DEPLETION ASSOCIATED WITH HIGH CIRCULATING ACTIVATOR ACTIVITY.
    VERSTRAETE M; AMERY A; VERMYLEN J; VERMYLEN C; DEVREKER R
    Br Med J; 1964 Mar; 1(5384):675-6. PubMed ID: 14096464
    [No Abstract]   [Full Text] [Related]  

  • 25. THE INHIBITION OF TRASYLOL OF FIBRINOLYTIC ACTIVITY ASSOCIATED WITH CARDIOVASCULAR OPERATIONS.
    TICE DA; WORTH MH; CLAUSS RH; REED GH
    Surg Gynecol Obstet; 1964 Jul; 119():71-4. PubMed ID: 14179354
    [No Abstract]   [Full Text] [Related]  

  • 26. THE EFFECT OF HEPARIN ON FIBRINOLYTIC ACTIVATORS AND PLASMIN.
    NILSSON IM; BIELAWIEC M; BJOERKMAN SE
    Scand J Haematol; 1964; 1():75-88. PubMed ID: 14175721
    [No Abstract]   [Full Text] [Related]  

  • 27. STUDIES ON THE ACTIVATION OF PLASMINOGEN. II. ON THE NATURE OF THE PROACTIVATOR.
    GUTMAN M; RIMON A
    Can J Biochem; 1964 Sep; 42():1339-45. PubMed ID: 14217241
    [No Abstract]   [Full Text] [Related]  

  • 28. [On practical execution of fibrinolysis therapy with enzyme preparations].
    DEUTSCH E; FISCHER M; STACHER A
    Folia Haematol (Frankf); 1961 Oct; 6():310-7. PubMed ID: 13885851
    [No Abstract]   [Full Text] [Related]  

  • 29. EFFECTS OF FEMALE HORMONES, USED AS ORAL CONTRACEPTIVES, ON THE FIBRINOLYTIC SYSTEM IN BLOOD.
    BRAKMAN P; ASTRUP T
    Lancet; 1964 Jul; 2(7349):10-2. PubMed ID: 14149193
    [No Abstract]   [Full Text] [Related]  

  • 30. [FIBRINOLYSIS, THROMBOLYSIS AND FIBRINOLYTIC TREATMENT].
    STOICHITA M
    Med Interna (Bucur); 1964 Oct; 16():1163-72. PubMed ID: 14244194
    [No Abstract]   [Full Text] [Related]  

  • 31. [THERAPEUTIC FIBRINOLYSIS. II. STUDIES ON THE EFFICACY OF STREPTOKINASE AND ACTASE IN VIVO].
    JUERGENS J
    Klin Wochenschr; 1964 Jun; 42():539-46. PubMed ID: 14233282
    [No Abstract]   [Full Text] [Related]  

  • 32. [Experimental animal thrombolysis tests with direct-action fibrinolytics].
    SAILER S; EBER O
    Klin Wochenschr; 1963 Mar; 41():212-6. PubMed ID: 13976107
    [No Abstract]   [Full Text] [Related]  

  • 33. ENHANCING BLOOD FIBRINOLYTIC ACTIVITY BY A NIACIN COMPOUND. II. ACTIVATION AND NONACTIVATION.
    AMERY A; VERMYLEN J; DEVREKER RA; VERMYLEN C
    Am J Med Sci; 1965 Jan; 249():66-71. PubMed ID: 14254831
    [No Abstract]   [Full Text] [Related]  

  • 34. [THE FIBRINOLYTIC THERAPY OF EXPERIMENTAL MASSIVE PULMONARY EMBOLISM IN RABBITS].
    MATTIOLI G; RABITTI G; NAVA C
    Minerva Cardioangiol; 1964 Jan; 12():25-8. PubMed ID: 14130219
    [No Abstract]   [Full Text] [Related]  

  • 35. [Studies on the effect of urokinase on the fibrinolytic activity of the blood].
    ANDREENKO GV; STRUKOVA SM
    Biokhimiia; 1962; 27():327-9. PubMed ID: 13861411
    [No Abstract]   [Full Text] [Related]  

  • 36. THE DEVELOPMENT OF IDEAS ON FIBRINOLYSIS.
    MACFARLANE RG
    Br Med Bull; 1964 Sep; 20():173-8. PubMed ID: 14216083
    [No Abstract]   [Full Text] [Related]  

  • 37. [PRESENT STATUS OF THROMBOLYTIC THERAPY].
    VAIREL EG; ANTOINE G
    Sangre (Barc); 1964; 41():441-6. PubMed ID: 14248832
    [No Abstract]   [Full Text] [Related]  

  • 38. PLASMA CHANGES DURING FIBRINOLYTIC THERAPY.
    JOHNSON JF; BARNHART MI; GILROY J; MEYER JS
    Vox Sang; 1963; 8():484-8. PubMed ID: 14059845
    [No Abstract]   [Full Text] [Related]  

  • 39. [CLINICAL ASPECT OF FIBRINOLYSIS].
    BARTA I
    Orv Hetil; 1963 Aug; 104():1590-3. PubMed ID: 14052314
    [No Abstract]   [Full Text] [Related]  

  • 40. A STANDARD CLOT METHOD FOR THE ASSAY OF PLASMINOGEN ACTIVATORS, ANTI-ACTIVATORS, AND PLASMIN.
    HAWKEY CM; STAFFORD JL
    J Clin Pathol; 1964 Mar; 17(2):175-81. PubMed ID: 14149945
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.